Daihan Scientific KRX:131220KOSDAQ
대한과학 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked0since Sep 11
In Q2 2026, Daihan Scientific reported revenue of ₩21.6bn, up 13.8% year on year, and operating profit of ₩2.1bn. Daihan Scientific (대한과학) appeared in 0 Korean news articles and 0 DART filings over the past seven days.
Filing signals Revenue & profit growth Screener
Daihan Scientific quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩21.6bn | +13.8% | ₩2.1bn margin 9.6% | ₩1.9bn |
| Q1 2026 | ₩17.6bn | +12.1% | ₩973m margin 5.5% | ₩917m |
| Q4 2025 derived | ₩25.2bn | +16.0% | ₩601m margin 2.4% | ₩166m |
| Q3 2025 | ₩21.2bn | +15.0% | ₩2.3bn margin 10.9% | ₩2.4bn |
| Q2 2025 | ₩19.0bn | +7.9% | ₩1.7bn margin 8.9% | ₩1.4bn |
| Q1 2025 | ₩15.7bn | +12.9% | ₩928m margin 5.9% | ₩824m |
| Q4 2024 derived | ₩21.7bn | +5.0% | ₩1.3bn margin 6.0% | ₩1.1bn |
| Q3 2024 | ₩18.4bn | +0.1% | ₩1.2bn margin 6.3% | ₩1.2bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Daihan Scientific top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest Daihan Scientific news Korean headlines
No articles yet.